
Thermo Fisher (TMO) Advances Health Equity via New Partnership
Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.

Thermo Fisher Scientific: A Good Buy Near The Bottom
Thermo Fisher Scientific is facing temporary revenue headwinds due to reduced COVID-19-related sales and cautious customer spending. The company's organic revenues are expected to bottom in FY24 an...

Thermo Fisher (TMO) Extends Partnership With Flagship Pioneering
Thermo Fisher's (TMO) in-depth knowledge of the life sciences sector will be combined with Flagship Pioneering to create revolutionary capabilities for the ecosystem.

Thermo Fisher Scientific reveals new $4B stock buyback program
Thermo Fisher Scientific (NYSE:TMO) Inc has announced a new $4 billion stock repurchase program, which represents about 2.3% of its market capitalization of $171.99 billion as of Monday's close. T...

Thermo Fisher sets new $4 billion stock buyback program, about 2 weeks after shares hit a 3-year low
Shares of Thermo Fisher Scientific Inc. TMO, -0.73% were little changed in premarket trading Tuesday, after the analytics, diagnostics and laboratory services company announced a new $4 billion sto...

Down 19% in 2023 So Far, Is Thermo Fisher Scientific Stock Still Worth Buying?
Thermo Fisher is seeing the collapse of its COVID-19 diagnostic business. It's also suffering from its customers tightening their purse strings.

Thermo Fisher Scientific Inc. (TMO) Q3 2023 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE:TMO ) Q3 2023 Earnings Call Transcript October 25, 2023 8:30 AM ET Company Participants Rafael Tejada - VP of IR Marc Casper - Chairman, President and CEO Stephe...

Thermo Fisher Cuts Its Outlook For Second-Straight Quarter Amid Weakening Market
Shares of Thermo Fisher Scientific (TMO) slumped over 7% in early trading Wednesday after the maker of lab equipment and analytical instruments posted weaker-than-expected sales and cut its outlook...

Thermo Fisher's stock on track for lowest close in more than three years after revenue miss and lowered guidance
Thermo Fisher Scientific Inc.'s stock TMO, -7.80% fell about 9% Wednesday to put it on track for its lowest close in more than three years, after the supplier of analytics, diagnostics and laborato...

Thermo Fisher lowers profit and sales outlook on soft demand, rising costs
Thermo Fisher Scientific (NYSE:TMO) issued a forecast for full-year profit and sales that falls below Wall Street expectations on lower-than-expected demand for its services used in the production ...

Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.69 per share, beating the Zacks Consensus Estimate of $5.58 per share. This compares to earnings of $5.08 per share a year ago.

Thermo Fisher Stock Slumps After Sales Miss and Outlook Is Slashed Again
The leading maker of scientific equipment slashes its guidance for the second consecutive quarter, citing a challenging macro environment.

Thermo Fisher cuts annual profit forecast on weak biotech demand
Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast for the second straight quarter, hurt by lower-than-expected demand for its services used to make therap...

Olink Holding stock soars on acquisition by Thermo Fisher Scientific
Olink Holding AB shares surged 66% to $24.87 in late-morning trading on Tuesday after the provider of next-generation proteomics solutions announced that it has agreed to be acquired by Thermo Fish...

Thermo Fisher to Buy Sweden's Olink for $3.1 Billion
Thermo Fisher will acquire proteomics company Olink for $26 per American depositary share in cash.
Related Companies